In Vitro Pharmacodynamic Studies of IDG-16177, a Potent GPR40 Agonist, for the Treatment of Type 2 Diabetes

被引：0
|
作者：
Yoon, Jongmin
Song, Haengjin
Lee, Don-Gil
Kim, Jung Ho
Hong, Dahae
Shin, Chorong
Jang, Eunhye
Kim, Jisu
Lee, Seolhee
Jun, Yearin
An, Kyungmi
Hong, Chang-Hee
Kwak, Hyun-Jung
Je, In-Gyu
Song, Hyo-Jung
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-122-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
122-LB
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A Multiple-Ascending-Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK-875, in Subjects With Type 2 Diabetes
    Leifke, E.
    Naik, H.
    Wu, J.
    Viswanathan, P.
    DeManno, D.
    Kipnes, M.
    Vakilynejad, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (01) : 29 - 39
  • [42] Synthesis, molecular docking, dynamic simulation and pharmacological characterization of potent multifunctional agent (dual GPR40-PPARγ agonist) for the treatment of experimental type 2 diabetes
    Hidalgo-Figueroa, Sergio
    Rodriguez-Luevano, Ana
    Almanza-Perez, Julio C.
    Giacoman-Martinez, Abraham
    Ortiz-Andrade, Rolffy
    Leon-Rivera, Ismael
    Navarrete-Vazquez, Gabriel
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 907
  • [43] Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes
    Xia, Yan
    Chackalamannil, Samuel
    Greenlee, William J.
    Jayne, Charles
    Neustadt, Bernard
    Stamford, Andrew
    Vaccaro, Henry
    Xu, Xiaoying
    Baker, Hana
    O'Neill, Kim
    Woods, Morgan
    Hawes, Brian
    Kowalski, Tim
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (11) : 3290 - 3296
  • [44] A novel GPR40 agonist HD-6277 comparison to Fasiglifam and LY2922470 in type 2 diabetic rats
    Kim, C.
    Kim, Y. -S.
    Yang, G.
    Kang, S.
    Lee, S.
    Choi, H. -S.
    Kim, D. -Y.
    Yoo, H. -E.
    Yang, J.
    Rhee, J. -K.
    Kim, D. -H.
    DIABETOLOGIA, 2017, 60 : S392 - S392
  • [45] Population Pharmacokinetics-Pharmacodynamics of the G-Protein Coupled Receptor 40 (GPR40) Agonist TAK-875 in Subjects with Type 2 Diabetes Mellitus (T2DM)
    Vakilynejad, Majid
    Wu, Jing-tao
    Viswanathan, Prabhakar
    Arora, Vipin
    Leifke, Eckhard
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1351 - 1351
  • [46] The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)
    Hamdouchi, Chafiq
    Kahl, Steven D.
    Lewis, Anjana Patel
    Cardona, Guemalli R.
    Zink, Richard W.
    Chen, Keyue
    Eessalu, Thomas E.
    Ficorilli, James V.
    Marcelo, Marialuisa C.
    Otto, Keith A.
    Wilbur, Kelly L.
    Lineswala, Jayana P.
    Piper, Jared L.
    Coffey, D. Scott
    Sweetana, Stephanie A.
    Haas, Joseph V.
    Brooks, Dawn A.
    Pratt, Edward J.
    Belin, Ruth M.
    Deeg, Mark A.
    Ma, Xiaosu
    Cannady, Ellen A.
    Johnson, Jason T.
    Yumibe, Nathan P.
    Chen, Qi
    Maiti, Pranab
    Montrose-Rafizadeh, Chahrzad
    Chen, Yanyun
    Miller, Anne Reifel
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (24) : 10891 - 10916
  • [47] Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes
    Kaku, Kohei
    Araki, Takahiro
    Yoshinaka, Ryoji
    DIABETES CARE, 2013, 36 (02) : 245 - 250
  • [48] A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of HD-6277, a Potent and Selective G-Protein-Coupled Receptor 40 (GPR40) Agonist, in Patients with Type 2 Diabetes Mellitus
    Kim, Ki-Hwan
    Yang, Hye-Jung
    Baek, Myoungki
    DIABETES, 2020, 69
  • [49] Pharmacokinetics (PK) & Pharmacodynamics (PD) of the GPR40 Agonist TAK-875 and Glimepiride Following Co-Administration in Subjects With Type II Diabetes (T2DM)
    Tsai, Max
    Lee, Ronald D.
    Vakilynejad, Majid
    Zhang, Wencan
    Marcinak, John
    Peng, Xuejun
    DIABETES, 2013, 62 : A303 - A303
  • [50] Palmitate-stimulated hormone secretion in relation to GPR40 expression in pancreatic islets of spontaneous obesity and type 2 diabetes in rats
    Salehi, A.
    Abaraviciene, S. Meidute
    Balhuizen, A.
    Kumar, R.
    Amisten, S.
    Olde, B. Bjorn
    Lundquist, I.
    DIABETOLOGIA, 2009, 52 : S166 - S167
12345